You are here
- Home
- Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
- PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trialsXiangjiao Meng, Yu Chen, Ligang Xing, Xinchao Liu, Kaikai Zhao, Liyang Jiang, Li Zhang, Caicun Zhou, Jinming YuBMJ Open Respiratory Research Sep 2022, 9 (1) e001294; DOI: 10.1136/bmjresp-2022-001294
- Cone beam CT-guided navigation bronchoscopy: a cost-effective alternative to CT-guided transthoracic biopsy for diagnosis of peripheral pulmonary nodulesStephan E P Kops, Roel L J Verhoeven, Robin J Vermeulen, Maroeska M Rovers, Erik H F M van der Heijden, Tim M GoversBMJ Open Respiratory Research Sep 2022, 9 (1) e001280; DOI: 10.1136/bmjresp-2022-001280
- Lung cancer in recipients after lung transplant: single-centre experience and literature reviewBilal Haider Lashari, Robert J Vender, Derlis Christian Fleitas-Sosa, Tejas Sinha, Gerard J CrinerBMJ Open Respiratory Research Apr 2022, 9 (1) e001194; DOI: 10.1136/bmjresp-2021-001194
- Diagnostic value and safety of thoracoscopic pleural biopsies in pleural exudative effusions of unknown origin, including follow-upEvan Patrick Deschuyteneer, Tom De KeukeleireBMJ Open Respiratory Research Mar 2022, 9 (1) e001161; DOI: 10.1136/bmjresp-2021-001161
- Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitorsLei Zhang, John Coffin, Kim Formenti, Quincy Chu, Iyare IzevbayeBMJ Open Respiratory Research Jan 2022, 9 (1) e001154; DOI: 10.1136/bmjresp-2021-001154
- Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgeryPeriklis Katopodis, Vladimir Anikin, Uday Kishore, Thomas Carter, Marcia Hall, Nizar Asadi, Andreas Polychronis, Emmanouil KarterisBMJ Open Respiratory Research Sep 2021, 8 (1) e000917; DOI: 10.1136/bmjresp-2021-000917
- Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)Sally Taylor, Janelle Yorke, Selina Tsim, Neal Navani, David Baldwin, Ian Woolhouse, John Edwards, Seamus Grundy, Jonathan Robson, Sarah Rhodes, Fabio Gomes, Fiona Blackhall, Corinne Faivre-Finn, Matthew EvisonBMJ Open Respiratory Research Jul 2021, 8 (1) e000846; DOI: 10.1136/bmjresp-2020-000846
- Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomasEmoke Papp, Anita Steib, Elhusseiny MM Abdelwahab, Judit Meggyes-Rapp, Laszlo Jakab, Gabor Smuk, Erzsebet Schlegl, Judit Moldvay, Veronika Sárosi, Judit E PongraczBMJ Open Respiratory Research Jun 2020, 7 (1) e000505; DOI: 10.1136/bmjresp-2019-000505
- Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer DatabaseErik F Blom, Kevin ten Haaf, Douglas A Arenberg, Harry J de KoningBMJ Open Respiratory Research May 2020, 7 (1) e000603; DOI: 10.1136/bmjresp-2020-000603
- Feasibility and acceptability of introducing advance care planning on a thoracic medicine inpatient ward: an exploratory mixed method studyNina Elisabeth Hjorth, Margrethe Aase Schaufel, Katrin Ruth Sigurdardottir, Dagny R Faksvåg HaugenBMJ Open Respiratory Research Feb 2020, 7 (1) e000485; DOI: 10.1136/bmjresp-2019-000485
Pages
- BMJ Open Respiratory Research
- Cough (3)
- Critical care (8)
- Cystic fibrosis (3)
- Lung cancer (9)
- Sleep (2)
- Thoracic surgery (1)
- Tuberculosis (2)